awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36060211-D4CF44B0-F03A-409C-9C88-1077ED832BB8
Q36060211-D4CF44B0-F03A-409C-9C88-1077ED832BB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36060211-D4CF44B0-F03A-409C-9C88-1077ED832BB8
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer.
P2860
Q36060211-D4CF44B0-F03A-409C-9C88-1077ED832BB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36060211-D4CF44B0-F03A-409C-9C88-1077ED832BB8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a212a5e8e6c76400de9ed3ec1e8ee02dc7918cc2
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr